Articles by Gerhard Symons - Pharmaceutical Executive


Articles by Gerhard Symons

Belgian innovation: truffles or waffle?

May 28, 2009

Gerhard Symons takes the Eurostar to Belgium to visit some of the leading biotechnology firms in the Bruges-Ghent-Leuven axis in the Flanders region, and unearths the origins of this fertile soil.

Reading the "Risk Radar"

May 6, 2009

Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a "risk radar" to your organization.

The million dollar question

Mar 31, 2009

Gerhard Symons realises that just one simple question can expose complex tensions between short-term profit motive, long-term market building and perception management of the industry.

Towards Pharma-Physician Transparency

Mar 3, 2009

This month, the Royal College of Physicians wil recommend a 'new covenant' between industry, clinicians and patients. The ABPI's Dr Richard Tiner, a working party member on the report, tells Gerhard Symons why transparency is key.

A True Industry-Academia Model

Jan 27, 2009

Industry is working more innovatively with academia on 'front-end' drug discovery. Gerhard Symons asks what this entails, and what are the challenges and rewards of this nascent paradigm?

Hits Like a BRIC

How to make sense of the growing diabetes market in Brazil, Russia, India, and China
Oct 1, 2007

The first wealth is health, wrote American thinker Ralph Waldo Emerson. Indeed, history has taught us (even before Emerson) that health and wealth are inextricably linked—the more money one has, the healthier one is likely to be.


Click here